ENLV
Enlivex Therapeutics Ltd.
$0.90
-$0.02(-1.72%)
20
Overall
--
Value
20
Tech
--
Quality
Market Cap
$23.33M
Volume
220.13K
52W Range
$0.84 - $2.10
Target Price
$10.00
Key Metrics Overview
| Market Cap | $23.33M | P/E Ratio | N/A |
| 52W High | $2.10 | 52W Low | $0.84 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | N/A | 52W Position | 4.5% |
| Overall Score | 20 | Value Score | -- |
| Quality Score | -- | Technical Score | 20 |
Growth Analysis
| EPS Current Est | $-0.45 | EPS Next Est | $-0.57 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
No data available
EBITDA (5Y)
No data available
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ENLV | $0.90 | -1.7% | 220.13K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Enlivex Therapeutics Ltd. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW